Novavax

World Rank (Aug-2026)

7980

Market Cap (Aug-2026)

1.328 Billion USD

Market Cap (Mar-08-2026)

1.626 Billion USD

World Rank (Jan-05-2024)

11,359

Market Cap (Jan-05-2024)

0.613 Billion USD

World Rank (Jul-30-2023)

10,617

Market Cap (Jul-30-2023)

0.708 Billion USD

World Rank (Jan-07-2022)

1,955

Market Cap (Jan-07-2022)

9.580 Billion USD

World Rank (Jan-01-2021)

2,119

Market Cap (Jan-01-2021)

7.527 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

NVAX

Employee Count

375

Employee Count as of Date

As on 2020

Headquarters City/State

Maryland

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

1,123 Million USD

Annual Operating Income in USD

453 Million USD

Annual Net Income in USD

440 Million USD

Annual Results for Period Ending

For year ending December-2025

Total Assets in USD

1,177 Million USD

Total Liabilities in USD

1,304 Million USD

Total Equity in USD

-128 Million USD

Balance Sheet for Period Ending

As of December-2025

Business Sector

Company Website

Wikipedia

Yahoo

Yahoo @ Frankfurt

Company Profile

Novavax is a Late Stage Biotechnology company that promotes improved global health through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company annual revenue is 157.0 million USD and 375 employees as on 2020. The headquarters is in USA.

Annual Results Summary

NOVAVAX - Yearly Revenue and Net Income - in Million USD:

Year - Ending	Revenue	Operating Income	Net Income
Dec-2021	1,146	-1.686 (Loss)	-1,743 (Loss)
Dec-2020	475	-416 (Loss)	-418 (Loss)
Dec-2019	18	-129 (Loss)	-132 (Loss)
Dec-2018	34	-173 (Loss)	-184 (Loss)